HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

NCT03886688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HEC53856
DRUG: placebo

Sponsor

Sunshine Lake Pharma Co., Ltd.